Produse farmaceutice
Information about customer
Title
CENTRUL PENTRU ACHIZITII PUBLICE CENTRALIZATE IN SANATATE
IDNO
1016601000212
Address
MOLDOVA,
locality,
MD-2009, Republica Moldova, Chişinău str. Cosmescu 3,
MD-2009
The contact person
Macari Doina,
doina.macari@capcs.md
Purchase data
ID
ocds-b3wdp1-MD-1666796221884
Title
Produse farmaceutice
Note
CPV Code
33600000-6 - Produse farmaceutice
Rationale
List of funding sources
Funding source cost
2829365.71 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666796221884-FS-1666798541495
IBAN
MD68TRPCCC518430A01859AA
Funding source cost
2829365.71 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666796221884-FS-1666796222825
IBAN
MD68TRPCCC518430A01859AA
Funding source cost
2829365.71 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666796221884-FS-1667820518912
IBAN
None
Funding source cost
2829365.71 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666796221884-FS-1667820518723
IBAN
MD68TRPCCC518430A01859AA
Funding source cost
2829365.71 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666796221884-FS-1668170078480
IBAN
None
Funding source cost
2829365.71 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666796221884-FS-1668170078307
IBAN
MD68TRPCCC518430A01859AA
Funding source cost
2829365.71 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666796221884-FS-1670342504106
IBAN
None
Funding source cost
2829365.71 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666796221884-FS-1670342503544
IBAN
None
Funding source cost
2829365.71 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666796221884-FS-1670342503718
IBAN
None
Funding source cost
2829365.71 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666796221884-FS-1670342503909
IBAN
None
Funding source cost
2829365.71 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666796221884-FS-1670342504366
IBAN
None
Funding source cost
2829365.71 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666796221884-FS-1670342503366
IBAN
MD68TRPCCC518430A01859AA
Funding source cost
2829365.71 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666796221884-FS-1670487300109
IBAN
MD68TRPCCC518430A01859AA
Funding source cost
2829365.71 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666796221884-FS-1670487300563
IBAN
None
Funding source cost
2829365.71 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666796221884-FS-1670487301567
IBAN
None
Funding source cost
2829365.71 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666796221884-FS-1670487300377
IBAN
None
Funding source cost
2829365.71 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666796221884-FS-1670487300835
IBAN
None
Funding source cost
2829365.71 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1666796221884-FS-1670487301022
IBAN
None
Status Planning
Start the procedure:
1 Jan 2023
1 Jan 2024
Date of publication: 26 Oct 2022 17:58
Date of last modifications: 20 Dec 2022 18:36